Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Initial clinical data for BDC-4182 Phase 1 dose escalation study expected in 3Q 2026 Cash balance of $38.8 million as of September 30, 2025 ...

Stepwise regression predicts Arctic sea-ice extent with high accuracy

Under the influence of global warming, the Arctic is transitioning from a state dominated by multi-year thick ice to a "New ...

WRN Inhibitors Market Enters Growth Phase with Multiple Early-Stage Clinical Programs Underway | DelveInsight

WRN inhibitors are attracting increasing attention as a niche but fast-emerging segment within precision oncology, driven by ...
Scientific Research Publishing

Analysis of Decision Support Systems (DSS) Integration with AI Using Mobile Health (m-Health) and Wearables ()

Wearables, Mobile Health (m-Health), Real-Time Monitoring Share and Cite: Alqarni, A. (2025) Analysis of Decision Support ...

DelveInsight Business Research, LLP: WRN Inhibitors Market Enters Growth Phase with Multiple Early-Stage Clinical Programs Underway | DelveInsight

WRN inhibitors are attracting increasing attention as a niche but fast-emerging segment within precision oncology, driven by their role in targeting DNA repair vulnerabilities.